Page last updated: 2024-09-02

liquiritigenin and Chronic Disease

liquiritigenin has been researched along with Chronic Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Hu, D; Hu, Z; Li, L; Wang, Y; Xu, H; Xu, Z; Yang, L; Zhang, L; Zhu, Y	1

Other Studies

1 other study(ies) available for liquiritigenin and Chronic Disease

Article	Year
Liquiritigenin alleviates doxorubicin-induced chronic heart failure via promoting ARHGAP18 and suppressing RhoA/ROCK1 pathway. Experimental cell research, 2022, 02-15, Volume: 411, Issue:2 Topics: Animals; Apoptosis; Cell Line; Chronic Disease; Disease Models, Animal; Down-Regulation; Doxorubicin; Flavanones; Gene Knockdown Techniques; Glycyrrhiza; GTPase-Activating Proteins; Heart Failure; Medicine, Chinese Traditional; Plants, Medicinal; Rats; Reactive Oxygen Species; rho GTP-Binding Proteins; rho-Associated Kinases; Signal Transduction	2022

Article

Year

Liquiritigenin alleviates doxorubicin-induced chronic heart failure via promoting ARHGAP18 and suppressing RhoA/ROCK1 pathway.

Experimental cell research, 2022, 02-15, Volume: 411, Issue:2

Topics: Animals; Apoptosis; Cell Line; Chronic Disease; Disease Models, Animal; Down-Regulation; Doxorubicin; Flavanones; Gene Knockdown Techniques; Glycyrrhiza; GTPase-Activating Proteins; Heart Failure; Medicine, Chinese Traditional; Plants, Medicinal; Rats; Reactive Oxygen Species; rho GTP-Binding Proteins; rho-Associated Kinases; Signal Transduction

2022